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pulse
Fariba Alaei-Shahmiri1,2*, Yun Zhao1 and Jill Sherriff1Abstract
Background: Arterial stiffness is an independent risk factor for cardiovascular disease and its progression may be
accelerated in the presence of hyperglycemia, either fasting or postprandial. The current study assessed vascular
function in subjects with pre-diabetes hyperglycemia, using digital volume pulse analysis technique.
Methods: We conducted a cross-sectional study examining vascular function in the fasting and postprandial
(glucose-induced) state in 44 adults, consisting of 17 subjects with pre-diabetic hyperglycemia and 27 normoglycemic
volunteers. Photoplethysmography of the digital volume pulse (DVP) was used to determine stiffness index (SI) and
reflective index (RI), as main measures of larger artery stiffness and vascular tone, respectively.
Results: Our results showed a significantly higher (Ln) fasting SI in the hyperglycemic group compared with the
control group (2.19 ± 0.32 vs. 1.96 ± 0.22, P = 0.005). However, this pattern reversed after adjustment for potential
confounders. In multiple linear regression analysis, (Ln) SI was related to age (β = 0.01, 95% CI: 0.01-0.02, P < 0.001)
and systolic blood pressure (SBP) (β = 0.01, 95% CI: 0.00-0.01, P < 0.05), but not with W/H, diastolic blood pressure
(DBP), fasting plasma glucose (FPG) or serum lipids. Furthermore, age (β = 0.02, 95% CI: 0.01-0.03, P < 0.001) and
mean arterial pressure (MAP) (β = 0.01, 95% CI: 0.00-0.02, P < 0.05) were found as the strong predictors of fasting SI
in hyperglycemic group. Neither FPG nor 2-h plasma glucose was a significant predictor for SI in hyperglycemic
group, after accounting for age and MAP. Subjects with hyperglycemia had a 15% blunted change in postprandial
AUCs for RI, adjusted for the respective baseline measurements (−9.40 ± 3.59 vs. -11.00 ± 2.84%) but these did not
attain statistical significance.
Conclusion: Increased arterial stiffness in pre-diabetic subjects is strongly associated with age and MAP. The
increased DVP-derived SI reported in patients with pre-diabetic hyperglycemia may result from different frequently
accompanied risk factors not just glycemic changes in this range.
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Arterial stiffness is a general term used to define the
stiffening of the arterial wall, resulting in a decreased
elasticity of the blood vessel. Although the pathogenesis
of arterial stiffness is not fully understood, changes in
the structure of the extracellular matrix, endothelial
function and vascular smooth muscle tone have been
implicated in its aetiology [1]. Arterial stiffness is an
independent risk factor for cardiovascular disease and
occurs mainly as a pathological consequence of ageing
[2]. However, its progression may be accelerated in the
presence of other risk factors, including hyperglycemia
in either diabetic or pre-diabetic ranges [3,4]. Hypergly-
cemia, either fasting or postprandial, has been shown to
enhance arterial stiffness through several mechanisms,
causing endothelial dysfunction as well as alternations in
the structure of vascular extracellular matrix [5-7].
Arterial stiffness can be evaluated by a variety of differ-
ent techniques. Pulse Trace PCA2 is a non- invasive
device used to assess vascular stiffness and endothelial
function by recording digital volume pulse (DVP). In
comparison with other available methods for arterial
stiffness assessment, pulse trace system is technically the
simplest, independent of operator skill, and validated in
different setting and diseases [8-10]. Also, its reproduci-
bility is consistent with other accepted methods [11].
Pulse Trace system analyses DVP waveform to deter-
mine two main measures of vascular function: stiffness
index (SI) and reflection index (RI).
The SI derived from DVP is an accepted measure of
large artery stiffness and correlates strongly with the
central pulse wave velocity (PWV, the ‘gold standard’
arterial stiffness parameter) as well as the augmentation
index determined by pulse wave analysis (PWA) method
[12]. SI derived from DVP was designed as a potent
discriminator of increasing cardiovascular complications
in patients with cardiovascular risk factors including
smoking, hypertension, diabetes, hypercholesterolemia
and central obesity [13]. However, the clinical utility of
this method in screening arterial stiffness in individuals
with hyperglycemia at pre-diabetic ranges is not well
known. The RI derived from DVP was suggested as a
reliable parameter reflecting the vascular tone of small
arteries [14]. Furthermore, response of RI to endothelium-
dependent vasoactive agents has been established as a
useful measure of endothelial function in individuals
with impaired glucose metabolism, hypertension and
coronary heart disease [8,15,16] that depends on
endothelial-derived nitric oxide (NO) [8]. It was shown
that postprandial hyperglycemia induced by oral glucose
loading alters endothelial function even in normal indi-
viduals [17,18]. Accordingly, the temporary impairment
of endothelium-dependent vasorelaxation observed fol-
lowing an oral glucose challenge has been alreadyconsidered as a measure to assess endothelial function in
individuals with hyperglycemia using other techniques in-
cluding the flow-mediated vasodilation (FMD) assessment
[19]. However, there has been no published literature
investigating the changes in RI after a glucose challenge
in subjects with hyperglycemia. Given these gaps, the
objective in this study was to assess vascular function in
the fasting and postprandial (glucose-induced) states in
subjects with pre-diabetes hyperglycemia, using this
technique.
Material and methods
Subjects
Forty four adults consisting of seventeen subjects with
pre-diabetic hyperglycemia and twenty seven normal
healthy volunteers, with BMI 27.8 ± 4.4 kg/m2 and aged
44.4 ± 15.2 years were recruited from the community.
Pre-diabetics were diagnosed by a fasting plasma glucose
level ≥ 6.1 mmol/l (110 mg/dl) and < 7.0 mmol/l (126 mg/dl),
and/or 2-h oral glucose tolerance test value ≥ 7.8 mmol/l
(140 mg/dl) and < 11.1 mmol/l (200 mg/dl) [20]. Exclu-
sion criteria were: smoking, known impaired renal or
liver function, females who were pregnant or lactating,
hypo- and hyperthyroidism and known diabetes mellitus.
No subject was on any medication which could affect
blood pressure, vascular function or metabolic out-
comes, and no subject had a albumin/creatinine ratio ≥
300 mg/g representing clinical proteinuria [21]. This
study was conducted according to the principal of the
Declaration of Helsinki and approved by the Curtin
University Human Research Ethics Committee (Approval
number HR 118/2008).
Study design and procedure
This cross-sectional study evaluated fasting and arterial
stiffness in individuals with impaired glucose regulation
relative to normal healthy volunteers. Following the
initial screening, eligible volunteers were informed about
the study’s protocol in detail during a short introductory
visit, and written consent was obtained from the sub-
jects. Participants were required to be on an unrestricted
diet that had at least 150–200 g of carbohydrate for the
three days prior to the test, and to consume a standard
meal provided by investigators on the evening before the
clinical day. They were also asked to refrain from alcohol
and strenuous exercise for the 24 h before the visit. On
the morning of the clinical day, subjects attended the
out-patient clinic, School of Public Health, Curtin Uni-
versity, following an overnight fast of 10–12 hours. An-
thropometric measurements were taken with subjects
dressed in a gown with no shoes and empty bladder.
Participants were then asked to rest 30 minutes prior to
the measurements of blood pressure and vascular func-
tion, and blood sampling. Fasting blood samples were
Alaei-Shahmiri et al. Journal of Diabetes & Metabolic Disorders  (2015) 14:23 Page 3 of 8collected via venipuncture into serum and plasma tubes.
Aliquots of separated plasma and serum were frozen
at −80°C until analysed. Following fasting measurements,
a 75-g oral glucose load was administrated to the subjects.
The second blood sample was taken 2 hours after the test
load.
Measurements of arterial blood pressure
After a mandatory rest period of 30 minutes, systolic and
diastolic blood pressures (SBP & DBP) were measured on
subjects’ right arms in supine position, using a vital signs
patient monitor (Cardiocap II, Datex, Helsinki, Finland)
with a standard cuff for adults. Three blood pressure
measurements, with 2-minutes intervals, were recorded
in the fasting state and the average value was reported.
Measurements of vascular function
Calculation of the indices derived from digital volume pulse
The technique of DVP is based on measuring infra-red
light transmission through the finger (photoplethysmo-
graphy) [8]. Photoplethysmography of DVP is used to
determine stiffness index (SI) and reflective index (RI),
as main measures of larger artery stiffness and vascular
tone of small arteries, respectively. RI is computed by
the% ratio of the heights (amplitude) of reflected wave
(diastolic component) to the systolic peak, and is a
measure of pulse wave reflection and the small artery
tone. SI can be calculated from the subject’s height di-
vided by the time between systolic and diastolic peaks,
and is a marker of large arterial stiffness [Figure 1] [11].
Arterial stiffness measurement protocol
Vascular function was assessed by a Pulse Trace machine
(PCA2, Micro Medical Ltd., UK), recording RI and SI as
the main indices determined from DVP analysis. photo-
plethysmography sensor transmitting infra-red light was
placed on the index finger of subjects. The digital volumeFigure 1 Indices derived from digital volume pulse analysis.
SI, stiffness index; RI, reflection index; PPT, peak-to-peak time.pulse measurements were recorded with subjects supine
in a temperature-controlled room (22 ± 2°C). Two read-
ings, at least 2 minutes apart, were taken in the fasting
state by the same researcher. Each of these measurements
was the average of three recordings with intervals of
30 seconds. Within-subject coefficients of variation were
8.01% and 6.03% for SI and RI measurements, respectively.
Subsequent measurements were made serially at 30, 60,
90 and 120 minutes after ingestion of the test load. The
changes in postprandial RI were determined by subtract-
ing the total area under the RI curve between 0 and 2 h
from the area below the baseline measurements, repre-
senting the change in the area for RI following consump-
tion of glucose load.
Biochemical measurements
The stored blood samples were analysed for markers of
metabolic control including: fasting and 2-h plasma
glucose, fasting and 2-h insulin, serum lipid profile
(triglyceride, total cholesterol, HDL-cholesterol and
LDL-cholesterol) and serum high-sensitivity C-reactive
protein (hs-CRP). Plasma glucose levels were deter-
mined with the hexokinase method. Insulin levels were
measured by the Architect insulin assay. The results of
fasting plasma glucose and insulin were also used to
estimate the hemostatic model assessment (HOMA-IR)
score, as an index of insulin resistance [22]. Enzymatic
colorimetric assays were used to determine the levels of
serum triglyceride and total cholesterol. Concentrations of
HDL-cholesterol were directly measured in the serum
samples by the Ultra HDL assay. Glucose, insulin and
lipid profile analyses were performed using the Abbott
diagnostic kits (Abbott Laboratories, IL, USA) with
a within- and between-run coefficient of variation
of < 4.3%. LDL-cholesterol was calculated using a modi-
fied version of Friedewald equation [23] with quantities
in mmol/l. Serum hs-CRP was measured by nephelome-
try using a BNII system (Siemens Healthcare Diagnostic
inc. Newwark, DE, USA) with between- and within-run
coefficient of variation of 8.35% and 5.7%, respectively.
Statistical analysis
All statistical analyses were performed using IBM SPSS
Statistics for windows (Version 19.0. IBM Corp. Released
2010. Armonk, NY: IBM Corp USA). An independent
samples t-test and a Mann–Whitney U test were used to
determine the significances of differences in mean and
median of the clinical measurements between study
groups, respectively. Correlation analysis was done by cal-
culating Pearson correlation coefficient (r) and Spearman’s
rank correlation coefficient (ρ). Multiple linear regression
analyses were carried out to explore the significant predic-
tors of being arterial stiffness as measured by stiffness
index (SI) and reflective index (RI), for all subjects and
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two-tailed and a P < 0.05 was considered as statistically
significant.
Results
The characteristics of hyperglycemic subjects [10 males,
7 females] and normal control volunteers [11 males, 16
females] participating in this study are presented in Table 1.
Participants were classified as normal or hyperglycemic
based on World Health Organisation criteria [20], using
venous plasma glucose measurements (FPG & 2-h GTT).
There were seventeen hyperglycemic subjects consisting
of twelve cases of impaired glucose tolerance (IGT) [six
cases with pure IGT and six cases with both elevated
fasting and 2-h plasma glucose] and five cases of im-
paired fasting glucose (IFG). Subjects in the hypergly-
cemic group were significantly older than normal
healthy volunteers (median: 60 y, IQR: 18 vs. median: 34 y,
IQR: 15; P < 0.001) and had greater waist circumference
(100.38 ± 11.47 cm vs. 88.70 ± 12.28 cm; P = 0.003), waist/hip
ratio (median: 0.93, IQR: 0.12 vs. median: 0.81, IQR: 0.13;
P=0.001), but similar BMI (normal group: 27.32±4.60 kg/m2,
hyperglycemic group: 28.50 ± 4.07 kg/m2). Both systolic
and diastolic blood pressure in the hyperglycemic group
were significantly higher than those of normal participants
(P < 0.001). There also were significant differences in
fasting and 2-h plasma glucose levels between study
groups (P <0.001) [Table 1].
The mean value (±SD) of (Ln) fasting SI measured in
the hyperglycemic group was significantly higher than
that of the normoglycemic group (2.19 ± 0.32 vs. 1.96 ±Table 1 Characteristics of participants in the study groups
Hyperglycemic group (n = 17)
Age (y) 60 (18.00)
BMI (kg/m2) 28.50 ± 4.07
WC (cm) 100.38 ± 11.47
W/H 0.93 (0.12)
SBP (mmHg) 121.24 ± 10.77
DBP (mmHg) 72.82 ± 8.70
Fasting glucose (mmol/l) 6.10 (0.55)
2-h glucose (mmol/l) 8.35 ± 1.16
Fasting insulin (μIU/ml) 6.5 (6.85)
2-h insulin (μIU/ml) 74.80 (66.05)
HOMA-IR 1.74 (2.00)
TG (mmol/l) 1.23 (0.79)
Total chol. (mmol/l) 5.17 ± 0.66
LDL-chol. (mmol/l) 3.22 ± 0.57
HDL-chol. (mmol/l) 1.22 ± 0.22
hs-CRP (mg/l) 1.41 (2.72)
Data are expressed as mean ± SD or as median (IQR) for skewed data.0.22, P = 0.005). However, this pattern changed after ad-
justment for potential confounders (age, sex, SBP, DBP
and W/H ratio) [Figure 2].
Fasting SI measured in all subjects was significantly
correlated with age (ρ = 0.78, P < 0.001), FPG (ρ = 0.54,
P < 0.001), SBP (ρ = 0.62, P < 0.001), DBP (ρ = 0.47, P =
0.001), pulse pressure (PP, ρ = 0.44, P < 0.01), mean arterial
pressure (MAP, ρ = 0.58, P < 0.001), WC (ρ= 0.35, P = 0.02)
and W/H ratio (ρ = 0.55, P < 0.001). The analysis per-
formed in the study groups showed that in the hypergly-
cemic group, fasting SI was significantly correlated with
age (ρ = 0.87, P < 0.001), FPG (ρ = 0.56, P = 0.02), SBP
(ρ = 0.56, P = 0.02), mean arterial pressure (ρ = 0.50,
P < 0.05) and W/H ratio (ρ = 0.57, P = 0.02). However,
fasting SI in the normoglycemic group remained corre-
lated only with age (ρ = 0.63, P < 0.001), mean arterial
pressure (ρ = 0.40, P < 0.05) and SBP (ρ = 0.48, P = 0.01).
There was no significant correlation between fasting SI
and lipid profile (P values > 0.05) [Table 2]. In the mul-
tiple linear regression analysis for all subjects, (Ln) fast-
ing SI was positively related to age (β = 0.01, 95% CI:
0.01-0.02, P < 0.001) and SBP (β = 0.01, 95% CI: 0.00-
0.01, P < 0.05), but not with W/H, DBP, FPG or serum
lipids. Furthermore, age (β = 0.02, 95% CI: 0.01-0.03,
P < 0.001) and mean arterial pressure (β = 0.01, 95% CI:
0.00-0.02, P < 0.05) were the strong predictors of fasting
SI determined in hyperglycemic group. Neither FPG nor
2-h PG were significant predictors for fasting SI, after
accounting for age and MAP in this group.
Hyperglycemic and normoglycemic groups had mean
(±SD) fasting RI 71.62% ± 10.62% and 68.96% ± 10.50%,Normal control group (n = 27) p- value
34 (15.00) <0.001
27.32 ± 4.60 0.40
88.70 ± 12.28 0.003
0.81 (0.13) 0.001
106.74 ± 9.50 <0.001
62.96 ± 6.11 <0.001
5.00 (0.50) <0.001
6.13 ± 0.93 <0.001
5.7 (3.60) 0.20
52.10 (26.40) 0.09
1.32 (1.00) 0.04
1.27 (0.93) 0.35
4.97 ± 1.12 0.50
2.99 ± 0.89 0.36
1.24 ± 0.28 0.83
0.88 (1.69) 0.56
Figure 2 Log-transformed fasting SI without adjustment (a); and
Log-transformed fasting SI, after adjusting for age, sex, SBP, DBP
and W/H, (b) determined in normal and hyperglycemic groups.
Data are presented as mean ± SEM. *, p < 0.01 compared to the normal
control group.
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group, subjects with hyperglycemia had a 15% blunted
change in postprandial AUCs for RI, adjusted for
the respective baseline measurements (−9.40 ± 3.59
vs. -11.00 ± 2.84%), though these did not attain statis-
tical significance (P > 0.05) [Figure 3].
There was a significant correlation between age and
the fasting RI in overall (r = 0.34, P < 0.05) and in hyper-
glycemic group (r = 0.81, P < 0.001), but not in normo-
glycemic group. Fasting RI determined in hyperglycemic
group was also significantly correlated with SBP (r = 0.56,
P < 0.05) and mean arterial pressure (r = 0.50, P < 0.05).
Also, there was no significant correlation between the
change in postprandial RI and age or other CVD risk fac-
tors assessed in all participants in this study (P > 0.05).However, the change in postprandial RI in hyperglycemic
group was significantly correlated with age (r = 0.52,
P < 0.05) and W/H ratio (r = 0.55, P < 0.05) [Table 2]. In
the multiple linear regression analysis for all partici-
pants, there was no significant relationship between
different clinical characteristics of the study subjects and
fasting RI or the change in postprandial AUC for RI. How-
ever, age was found as a significant predictor of fasting RI
where the analyses were performed in the hyperglycemic
group (β = 0.67, 95% CI: 0.40-0.94, P < 0.001). Further-
more, a regression model including gender (Female:
β = −17.05, 95% CI: −32.34–1.76, P = 0.03), WC/HC
(β = 169.49, 95% CI: 58.41-280.58, P = 0.007), FPG
(β = −30.05, 95% CI: −51.39–8.7, P = 0.01), total chol-
esterol (β = 27.16, 95% CI: 6.83-47.48, P = 0.01), LDL-
cholesterol(β = −42.82, 95% CI: −66.92–18.71, P = 0.003),
2-h PG (β = 8.7, 95% CI: 3.20-14.22, P = 0.005) could
predict 72.5% of variability in the change in postpran-
dial AUC for RI in the hyperglycemic group. These
variables also remained as significant predictors after
adding the respective baseline measurements (P > 0.05)
to the model.
Discussion
It is known that hyperglycemia in either diabetic or pre-
diabetic range (IFG, IGT) is associated with a high risk
of CVD and mortality [24-26]. While, exact mechanisms
through which hyperglycemia increases cardiovascular
risk have not been fully elucidated, increased central and
peripheral arterial stiffness has been demonstrated as a
potential explanation [3]. Aggravated arterial stiffness
has been evident in individuals with IFG and IGT, in
which arterial stiffness has mainly been assessed using
PWV [27-29]. The SI derived from DVP has been re-
ported to be significantly higher in patients with CVD
risk factors including diabetics [13]. However, the clin-
ical utility of this technique in screening arterial stiffness
in individuals with pre-diabetic hyperglycemia is not well
established. The current study is among the first [15,30]
investigating arterial stiffness in pre-diabetic patients by
this method.
In the present study, fasting stiffness index measured
in subjects with pre-diabetic hyperglycemia was signifi-
cantly higher than that of normoglycemic subjects. How-
ever, this trend changed when data were adjusted for other
cardiovascular risk factors as potential confounders
[Figure 2]. Also, despite significant positive correlations
between fasting SI and age, FPG, WC, W/H ratio, SBP
and DBP; based on multivariate regression analysis, age
and blood pressure (SBP/MAP), but not FPG, or 2-h PG
were found as the strong predictors of SI determined in
all subjects and in the hyperglycemic group. These find-
ings suggest that the higher DVP-derived SI found in
pre-diabetic patients may have resulted from a cluster
Table 2 Correlations between DVP-derived indices and clinical characteristics of participants in overall and in the study
groups
Characteristics Hyperglycemic group Normoglycemic group All subjects
F.SI F.RI Δ PP. RI F.SI F.RI Δ PP. RI F.SI F.RI Δ PP. RI
Age (y) 0.87c 0.81c 0.52a 0.63c −0.008 −0.06 0.78c 0.34a 0.16
BMI (kg/m2) −0.12 0.02 0.02 0.25 0.03 0.26 0.17 0.04 0.19
WC (cm) 0.14 0.26 0.31 0.22 0.04 0.25 0.35a 0.16 0.26
W/H 0.57a 0.48 0.55a 0.33 0.09 −0.11 0.55c 0.23 0.09
SBP (mmHg) 0.56a 0.56a 0.18 0.48b 0.08 0.12 0.62c 0.3 0.14
DBP (mmHg) 0.34 0.4 0.15 0.3 −0.02 0.03 0.47b 0.21 0.09
PP (mmHg) 0.35 0.30 0.08 0.31 0.15 0.15 0.44b 0.24 0.14
MAP (mmHg) 0.50a 0.50a 0.18 0.40a 0.02 0.07 0.58c 0.26 0.11
FPG (mmol/l) 0.56a 0.42 0.32 0.35 0.03 −0.12 0.54c 0.2 0.05
2-h PG (mmoI/l) −0.44 −0.46 −0.13 0.51b 0.08 0.19 0.34a −0.01 0.07
HOMA-IR 0.03 0.03 0.16 0.15 −0.23 0.1 0.22 −0.002 0.13
TG (mmol/l) 0.01 −0.12 0.21 0.32 0.01 0.12 0.25 −0.02 0.15
Total Chol. (mmol/l) −0.03 −0.08 −0.07 0.23 0.14 0.1 0.2 0.09 0.06
HDL-Chol. (mmol/l) −0.05 −0.01 0.06 0.08 0.25 −0.19 0.05 0.16 −0.12
LDL-Chol. (mmol/l) −0.19 −0.11 −0.23 0.23 0.08 0.14 0.16 0.04 0.05
hs-CRP(mg/l) −0.34 −0.23 −0.05 0.35 0.12 0.14 0.12 −0.14 0.12
Data are expressed as correlation coefficient; F.SI, Fasting RI; Δ PP. RI, Change in postprandial AUC for RI from the baseline; PP, pulse pressure; MAP, Mean arterial
pressure; ap < 0.05, bp < 0.01, cp < 0.001.
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not merely the glycemic changes. In keeping with this
result, Gunarathne et al. reported age and MAP as
significant predicators of SI derived from DVP [13].
Also, they found no significant relationship between
fasting SI and FPG on multivariate regression analysis.Figure 3 Changes in the post-glucose challenge RI observed in
normal and hyperglycemic groups. Data are presented as mean
± SEM of the change in the postprandial AUC from the baseline, and
are adjusted for the baseline measurements. *, p < 0.05 compared to
the normal control group.Similarly, a systematic review of 77 published literatures
showed that large artery stiffness assessed by PWV has
been more significantly associated with age and blood
pressure than other risk factors [31]. The results of our
study are partially consistent with the findings of Chou
et al. [30] who recently reported higher fasting SI
derived from DVP in subjects with pre-diabetes mellitus
compared to individuals without hyperglycemia. In
that study, participants with pre-diabetes mellitus had
significantly higher age, WC, SBP and DBP as well as
lower HDL-cholesterol compared to participants without
hyperglycemia. It is known that the prevalence of hyper-
glycemia increases with age [32], which is also the main
determinant of arterial stiffness [2]. In addition, impaired
glucose metabolism has been shown to be strongly associ-
ated with other atherosclerotic risk factors including
dyslipidemia, hypertension and obesity [33-35]. In the
study conducted by Chou and his colleagues no data were
provided about the mean SI in the study groups estimated
after adjustment for these variables. Thus, the significant
difference in DVP-derived SI reported in that study could
be also due to other frequently accompanied risk factors
rather than just the increased blood glucose at these
levels.
According to our results, fasting SI was correlated
more strongly with age, while there was a weak relation-
ship between fasting RI and age. In keeping with this,
Millasseau et al. [36] suggested SI as a more reliable
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more, Woodman and Watts [11] indicate that the SI
derived from DVP analysis provides an estimation of
large artery stiffness which is strictly linked to age-
related changes.
While differences in fasting and postprandial RI values
between the two groups were not statistically significant,
they may be important from a clinical view. DVP derived
RI is mainly related to the tone of small arteries which
can be altered in the presence of hyperglycemia [37].
Moreover, blunted response of RI to endothelium-
dependent vasoactive agents has been established as a
marker of endothelial dysfunction in individuals with
high cardiovascular risk, including those with impaired
glucose metabolism [8,15,16,38]. It was shown that
endothelium-dependent vasodilation is reduced after an
oral glucose loading even in normal individuals [17,18].
To the best of our knowledge, this is the first study
investigating the changes in RI in subjects with hypergly-
cemia following a glucose challenge, using the digital
volume pulse analysis technique.
The effect of oral glucose (usually 75 g administrated
in a standard oral glucose tolerance test) on endothelial
function has been mainly assessed by the change in the
flow-mediated vasodilation (FMD) assessment. FMD was
shown to decrease within 1 hour after ingestion of the
glucose load by healthy subjects as well as patients with
IGT and diabetes [19]. However, the change in the
post-prandial FMD was more significant in diabetic or
impaired glucose tolerant patients, compared to subjects
with normal glucose metabolism.
Several mechanisms are thought to account for the
temporary impairment of endothelium-dependent vaso-
relaxation observed following an oral glucose challenge,
including generation of oxidative stress and free radicals,
a transient loss of NO bioavailability, and a reduction in
antioxidant defence systems [17,19,39].
In the present study, a tendency toward a blunted
response of DVP-derived parameters (RI) to the oral
glucose challenge in subjects with impaired glucose
metabolism is consistent with impaired endothelium-
dependent vasodilation in these patients, as shown by
others in the FMD assessments. In agreement with our
results, Gopaul et al. [15] reported a trend toward a
reduced change in the RI derived from DVP analysis
following inhalation of salbutamol in subjects with im-
paired glucose tolerance, which became significant in
newly diagnosed and established diabetes. Similarly,
Chowienczyk et al. [8] showed an attenuated response of
RI to inhaled albuterol (salbutamol) in patients with type
2 diabetes mellitus, compared to control subjects.
Given the evidence of changes in FMD following an
oral glucose challenge in subjects with hyperglycemia
as well as the reduction in photoplethysmographic digitalvolume pulse parameters under salbutamol inhalation, it
can be expected that evaluating DVP analysis following an
oral glucose challenge could provide additional information
in the assessment of vascular function, particularly in newly
diagnosed diabetic patients. Further research with a larger
sample size is required to extend these encouraging outcomes.
Conclusion
In the current study, we found age and MAP as the strong
predictors of increased arterial stiffness among pre-
diabetic subjects. Our findings suggest that the higher
DVP-derived SI in patients with pre-diabetic hypergly-
cemia may result from different frequently accompanied
cardiovascular risk factors rather than merely glycemic
changes in this range. We also observed a sizeable
reduction in postprandial RI that if confirmed in a
larger group of individuals it would indicate a derange-
ment of vascular function in hyperglycemia.
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